Referencing for people who value simplicity, privacy, and speed.Get Citationsy
← Back to Search
Ear Pinna : A Privileged DNA Electroporation Site For Inducing Strong Th1 Immune Responses
J. Ni, Britta Nolte, G. Vandermeulen, V. Préat, D. Scherman, V. Schirrmacher, P. Fournier
Published 2009 · Biology
Save to my Library
Download PDFAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
DNA vaccination appears a very attractive approach for inducing immune responses towards the encoded anti- gen, but studies in large animals and in humans revealed weaknesses of such responses. In this study, we evaluated a new approach based on a new device combining DNA vaccination with electroporation (EP) at the ear pinna site. Under opti- mal EP conditions, the expression of the DNA encoded antigen and the induced immune responses were considerably in- creased. Very interestingly, DNA vaccination using EP at the ear pinna induced much stronger cellular immune responses than at the flank skin although antigen expression was similar at both sites. As compared to vaccination at the ear pinna without EP, IFN- but not IL-4 production by splenocytes from immunized mice was significantly enhanced. In contrast, IL-4 but not IFN- production was increased by EP at the flank skin. The vaccination site of the ear pinna combined with EP route even provided therapeutic effects in a mouse tumor model. In conclusion, this study highlights the ear pinna as a privileged site for the induction of strong Th1 polarized cellular im- munity against a defined antigen when combining DNA vaccination with EP.
This paper references
Exploiting dendritic cells to improve vaccine efficacy.
R. Steinman (2002)
DNA vaccines—back in the saddle again?
K. Powell (2004)
An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems
N Puri (2000)
Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of Human Immunodeficiency Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation
J. Liu (2008)
DNA vaccinesin the saddle again ?
K Powell (2004)
Transforming Growth Factor-β and the Immune Response to Malignant Disease
B. Teicher (2007)
An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems.
N. Puri (2000)
Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus
J. Donnelly (1995)
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer.
M. Bureau (2000)
Gene Therapy Progress and Prospects: Electroporation and other physical methods
D. Wells (2004)
Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy.
B. Brown (2002)
Mechanism of in vivo DNA transport into cells by electroporation: electrophoresis across the plasma membrane may not be involved
F. Liu (2006)
Topical application of viral vectors for epidermal gene transfer.
B. Lu (1997)
Gene expression and immune response kinetics using electroporation‐mediated DNA delivery to muscle
Eirik Grønevik (2005)
Puncture-mediated gene transfer to the skin.
I. Ciernik (1996)
Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity.
Baowei Peng (2007)
Cytokine gene expression in epidermis with biological effects following injection of naked DNA
U. Hengge (1995)
immu - nogenicity
JP Scheerlinck (2007)
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.
R. Deck (1997)
Immunization of livestock with DNA vaccines: current studies and future prospects.
S. van Drunen Littel-van den Hurk (2001)
Dendritic cells and the control of immunity
J. Banchereau (1998)
Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response
K. Jurianz (1998)
Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine
V. Schirrmacher (2000)
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
Z. Wang (2004)
In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA.
A. V. Titomirov (1991)
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
B. Verstrepen (2008)
Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
R. Wang (2001)
Electroporation Enables Plasmid Vaccines to Elicit CD8+ T Cell Responses in the Absence of CD4+ T Cells1
K. Dayball (2003)
Taking electroporation-based delivery of DNA vaccination into humans: a generic clinical protocol.
T. Tjelle (2008)
The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium
A. Rubartelli (1997)
Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery
J. Mikszta (2002)
DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
O. Akbari (1999)
DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
M. Spellerberg (1997)
Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates
S. Capone (2006)
Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles
F. Polack (2000)
Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma.
A. Smorlesi (2006)
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
G. Widera (2000)
Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines.
R. Hawkins (1994)
Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.
K. Okuda (2001)
Superiority of the ear pinna over muscle tissue as site for DNA vaccination
P. Foerg (1998)
Strategies for effective naked-DNA vaccination against infectious diseases.
P. Chiarella (2008)
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
J. Ni (2009)
Erratum: Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles (Nature Medicine (2000) 6 (776-781))
F. Polack (2000)
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.
J. C. Liao (2006)
Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer.
S. Šatkauskas (2005)
Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases.
L. Zhang (1996)
DNA vaccines for aquacultured fish.
N. Lorenzen (2005)
Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
S. Babiuk (2000)
Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity.
G. Wildbaum (2003)
Charac - terization of humoral immune responses induced by an influenza hemagglutinin DNA
RR Deck (1990)
FVIII gene delivery by muscle electroporation corrects murine hemophilia A
Y. Long (2005)
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
P. Bergman (2006)
A novel electroporation device for gene delivery in large animals and humans.
T. Tjelle (2006)
Direct gene transfer into mouse muscle in vivo.
J. Wolff (1990)
This is an open-access article,...
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
S. Kadowaki (2000)
In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells1
G. Ahlén (2007)
Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption.
T. Nishijima (1997)
Microfabricated microneedles for gene and drug delivery.
D. Mcallister (2000)
Gene transfer into muscle by electroporation in vivo.
H. Aihara (1998)
DNA fusion gene vaccines against cancer: from the laboratory to the clinic
F. Stevenson (2004)
Enhancement of DNA Vaccine Potency through Coadministration of CIITA DNA with DNA Vaccines via Gene Gun1
D. Kim (2008)
Langerhans cells cross-present antigen derived from skin
P. Stoitzner (2006)
Potentiation of an anthrax DNA vaccine with electroporation.
A. Luxembourg (2008)
DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants
D. Pokorná (2008)
DNA transfection of mononuclear cells in muscle tissue
Eirik Grønevik (2003)
Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.
R. Wang (1998)
Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes.
I. Ciernik (1996)
G. Nahir MA Wildbaum
Early events of electroporationmediated intramuscular DNA vaccination potentiate Th 1directed immune responses
E Gronevik (2005)
Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
Lauren A. Hirao (2008)
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody.
H. Davis (1993)
Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function.
J. Schertzer (2006)
Immunization of dogs with a DNA vaccine induces protection against rabies virus.
P. Perrin (1999)
DNA vaccination and gene therapy: optimization and delivery for cancer therapy
Angela M Bodles-Brakhop (2008)
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.
R. Macgregor (1998)
Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
A. Roos (2006)
A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer
P. Lefesvre (2002)
Electroporation gene therapy: new developments in vivo and in vitro.
S. Li (2004)
Therapy Clinical Trials Worldwide – Chart&Table Keyword: Vec- tors (Updated March 2009) available from http
Mechanism by which electroporation mediates DNA migration and entry into cells and targeted tissues.
M. Rols (2008)
The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium.
A. Rubartelli (1997)
Delivery of DNA into tumors.
S. Li (2008)
Scattered micrometastases visualized at the single‐cell level: Detection and re‐isolation of lacZ‐labeled metastasized lymphoma cells
A. Krüger (1994)
Immune response to a carcinoembryonic antigen polynucleotide vaccine.
R. Conry (1994)
DNA vaccines: immunology, application, and optimization*.
S. Gurunathan (2000)
Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis.
S. Šatkauskas (2002)
Modification of tumor cells by a low dose of Newcastle Disease Virus.
Paul Von Hoegen (1989)
Genetic immunization is a simple method for eliciting an immune response
D. Tang (1992)
Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes
M. Albert (1998)
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
S. Calarota (1998)
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
P. Bergman (2003)
High-efficiency gene transfer into skeletal muscle mediated by electric pulses.
L. Mir (1999)
Licensee Bentham Open
C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis.
S. Youssef (2000)
Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response.
P. von Hoegen (1988)
A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
C. Tsang (2007)
Immunization with DNA through the skin.
Kristina K. Peachman (2003)
DNA electrotransfer: its principles and an updated review of its therapeutic applications
F. Andre (2004)
J Clin Invest
Heterologous protection against influenza by injection of DNA encoding a viral protein.
J. Ulmer (1993)
Immunoprophylaxis of allergen–induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization
Ching-Hsiang Hsu (1996)
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice1
M. Dupuis (2000)
Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.
Angela M Bodles-Brakhop (2009)
DNA-based therapeutics and DNA delivery systems: A comprehensive review
S. Patil (2008)
H. L. Robinson (1996)
Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques
A. Luckay (2007)
Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides.
S. Uno-Furuta (2001)
Antigen presentation and DNA vaccines.
J. Donnelly (2000)
Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins
G. Otten (2005)
Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188.
J. Hartikka (2001)
DNA vaccines: progress and challenges
JJ Donnelly (2005)
Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.
J. Ulmer (1994)
Applicator and electrode design for in vivo DNA delivery by electroporation.
D. Rabussay (2008)
Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds.
E. Badiavas (1996)
Electropermeabilization of skeletal muscle enhances gene transfer in vivo
I. Mathiesen (1999)
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
M. Sedegah (1994)
Use of Plasmid DNA for Direct Gene Transfer and Immunization
H. Davis (1995)
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.
M. Molnár (2004)
Early events of electroporation‐mediated intramuscular DNA vaccination potentiate Th1‐directed immune responses
Eirik Grønevik (2005)
Inflammatory cytokines and antigen presenting cell activation.
M. Murtaugh (2002)
In vivo electroporation improves immune responses to DNA vaccination in sheep.
J. Y. Scheerlinck (2004)
In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment.
N. Yang (1990)
This paper is referenced by
The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
J. Ni (2010)
The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
G. Vandermeulen (2015)
Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity.
J. Ni (2011)
Suicide genes in a novel vaccination strategy for hepatitis C.
Hugh Trahair (2012)
Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination
Prabhu S. Arunachalam (2016)